Health
Hong Kong’s PHASE Scientific raises $34M Series A round to advance urine-based diagnostic technology for early disease detection
PHASE Scientific International Limited, a Hong Kong-based biotechnology company, announced Tuesday the successful completion of a $34 million Series A funding round.
The firm said in a statement that this represents the largest Series A raise in Asia’s diagnostic technology sector since 2019, reflecting robust investor conviction in PHASE Scientific’s innovative PHASIFY™ technology and ambitious growth strategy.
The funding round is led by a private equity fund managed by...
Malaysia’s Betamek partners Singapore’s SiGenex for AI genomics diagnostic and sequencing solution
Betamek Berhad, a Malaysia-based original design manufacturer (ODM), has partnered with SiGenex Global Holdings Pte. Ltd. (SiGenex), a Singapore-based technology firm, for artificial intelligence (AI) genomics diagnostic and sequencing solution.
Betamek said in a statement that the firm, through its wholly-owned subsidiary Betamek Research Sdn. Bhd. (BRSB) has entered into a memorandum of collaboration (MoC) with SiGenex for the partnership.
The collaboration aims to jointly explore a...
Unlocking Southeast Asia’s multi-billion dollar biotech potential With AI
Southeast Asia’s biotech and healthtech sectors are gaining momentum, driven by government-led initiatives like Singapore’s National Precision Medicine Strategy and Thailand’s “Thailand 4.0” plan. These efforts aim to drive R&D and deliver more personalized, data-driven healthcare solutions.
Artificial intelligence sits at the heart of this transformation, promising faster drug discovery, improved diagnostics, and more targeted treatments. Yet despite its...
How AI is enhancing APAC telehealth
Telehealth services are seeing a major shift in the Asia-Pacific (APAC) region, with artificial intelligence playing a central role. From automated patient monitoring to real-time diagnostics, AI addresses critical healthcare challenges across clinical practices. But how instrumental is AI in helping improve patient outcomes in the region, and where do APAC countries stand in its implementation?
The state of telehealth in APAC
With the APAC telehealth industry reaching $8.07 billion in 2024...
Singapore’s Nuevocor raises $45M Series B for Novel Cardiomyopathy therapy development
Nuevocor, a Singapore-headquartered IND-stage biotechnology company developing cures for cardiomyopathies driven by aberrant mechanobiology, has announced the successful completion of $45 million Series B financing.
The round was co-led by Kurma Partners and Angelini Ventures, with significant participation from existing investors EDBI, ClavystBio and Boehringer Ingelheim Venture Fund, alongside Highlight Capital and SEEDS Capital, Nuevocor said in a statement on Tuesday.
Nuevocor also...
Creador acquires minority stake in Vietnam’s pharmacy chains FPT Long Chau Investment JSC
Creador, a Malaysia-based private equity firm in South and Southeast Asia, has announced the acquisition of up to 13 percent in FPT Long Chau Investment JSC (Long Chau), one of Vietnam’s leading pharmacy chains.
This marks the first ever fundraise by Long Chau and the second investment made in Vietnam by Creador, Creador said in a statement on last Friday.
Long Chau has grown from four stores in 2017 to over 2,000 pharmacies and over 140 vaccination centers in Vietnam today.
It is...
The human code: How physical AI is rewriting the future of care
By the time you finish reading this article, somewhere in the world, a robot will have helped a stroke survivor move an arm, reminded an elderly patient to take their medication, or encouraged a toddler to get active. Physical artificial intelligence (AI) isn’t just testing our technological capability. It is testing our values.
Across aged care, education, and hospitals, physical AI – robots that move, sense, and interact in the real world – is emerging as a powerful and...
Malaysia’s digital third-party administrator HealthMetrics launches in Indonesia
HealthMetrics, a Malaysia-based digital third-party administrator (TPA), announced the official launch of HealthMetrics Indonesia – uniting the longstanding expertise of Across Asia Assist Indonesia (AAA) with its advanced digital infrastructure to create a single, integrated digital TPA powerhouse poised to transform healthcare administration in Indonesia and Southeast Asia.
HealthMetrics said in a statement on last Friday that for over a decade, Across Asia Assist Indonesia has...
How AI is transforming healthcare accreditation processes
Healthcare accreditation is a vital benchmark for quality, safety, and compliance in medical institutions. In Southeast Asia and the broader Asia-Pacific (APAC) region, artificial intelligence (AI) is emerging as a transformative force, streamlining accreditation processes and enhancing healthcare delivery.
AI’s role in streamlining accreditation
AI technologies are revolutionizing how healthcare institutions approach accreditation by automating complex tasks and enhancing data...
Li Ka Shing Foundation, Temasek Trust jointly commit $9M to acquire systems and advance clinical trial for innovative histotripsy cancer therapy in Singapore
The Li Ka Shing Foundation (LKSF) and Temasek Trust (TT) have committed S$12 million ($8.99 million) to bring innovative non-invasive ultrasound-based histotripsy tumor clinical trials to Singapore.
The duo said in a statement on Friday that the National Cancer Centre Singapore (NCCS) and the National University Cancer Institute, Singapore (NCIS) will each receive one Histotripsy System – the first of such to be available in Southeast Asia.
The funding from LKSF and TT will also...
Temasek renews investment in global animal health firm Ceva Animal Health
Ceva Animal Health (Ceva), the world’s fifth-largest animal health company, said the Singapore-based global investment firm Temasek has renewed its investment in the company.
Ceva announced in a statement on Monday the restructuring of its capital.
According to the statement, all investors including pure investors led by Temasek, have renewed their investment, demonstrating their confidence in the company’s ability to continue its sustained growth.
It noted the long-standing...
Temasek and GIC acquire stake in Singapore-headquartered biotech specialist CRO Novotech
Novotech, Singapore-headquartered full-service biotech specialist clinical research organization (CRO), announced that affiliates of GIC and Temasek have signed binding agreements to acquire a significant stake in the company, with the additional capital earmarked to accelerate its global growth.
Existing investor TPG will also reinvest through its TPG Asia fund, Novotech said in a statement on last Sunday.
According to the statement, the reinvestment by TPG Asia and investment from GIC and...
More Blogs
Sponsored
Read More
East Ventures, SV Investment announce first close of $100M Southeast Asia-South Korea investment corridor fund
East Ventures, a venture capital firm in Indonesia and Southeast Asia, and SV Investment, a...
Turkey Tetrazzini
If you like Turkey Tetrazzini, you'll love this easy-to-make "from scratch" version even more...
Singapore’s Syfe offers to acquire ASX-listed investment platform Selfwealth for $41M
Syfe, a Singapore-based saving and investment platform, has made a non-binding indicative offer...
NUS expands start-up hub in Tokyo to propel deep tech innovation
NUS Enterprise, the entrepreneurial arm of the National University of Singapore (NUS), is...
Malaysia, Japan seal $310M in green bioeconomy
Malaysia and Japan have marked a new milestone in green bioeconomy cooperation with the signing...